Anti-ischemic properties of calcium-channel blockers: Lessons from cardiac surgery

Journal of the American College of Cardiology

Volumn 41, Issue 9, 2003, Pages 1506-1509

  Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMLODIPINE; ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIURETIC AGENT; GLYCERYL TRINITRATE; LACIDIPINE; NICARDIPINE; NIFEDIPINE; NITRATE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANALYTICAL ERROR; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONVALESCENCE; CORONARY ARTERY DISEASE; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HUMAN; HYPERTENSION; INTRAOPERATIVE PERIOD; MEDICAL LITERATURE; MEDICAL SOCIETY; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REVIEW; SAMPLE SIZE; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038070455     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00192-X     Document Type: Editorial

References (23)

1. Holland Inter-university Nifedipine Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit, a randomised, double-blind placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Holland Inter-university Nifedipine Trial. Br Heart J 1986;56:400-13.
2. Göbel EJ, Hautvast RW, van Gilst WH, et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995;346:1653-7.
3. Opie LH, Yusuf S, Kübler W. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases. A critical analysis based on 100 studies. Prog Cardiovasc Dis 2000;43:171-96.
4. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med 1996;335:1713-20.
5. Mangano DT, Wong MG, London MJ, Tubau JF, Rapp JA. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - II: incidence and severity during the 1st week after surgery. J Am Coll Cardiol 1991;17:851-7.
6. Wijeysundera DN, Beattie WS, Rao V, Karski J. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a metaanalysis. J Am Coll Cardiol 2003;41:1496-505.
7. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-900.
8. Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
9. Flather M, Yusuf S, Køber L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancer 2000;355:1575-81.
10. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. A meta-analysis. Circulation 2002;106:75-80.
11. Furberg CD, Psaty BM, Meyer JV. Nifedipine dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
12. Opie LH, Schall R. Evidence-based evaluation of calcium channel blockers (CCBs) for hypertension. Equality of mortality and cardiovascular risk relative to conventional therapy. J Am Coll Cardiol 2002;39:315-22.
13. Gibbons RJ, Chatterjee K, Daley J, et al. ACC/AHA/ACP/ASIM guidelines for the management of patients with chronic stable angina: the report of the ACC/AHA Task Force Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092-197.
14. Opie LH. First line drugs in chronic stable effort angina - the case for newer, longer-acting calcium channel blocking agents. J Am Coll Cardiol 2000;36:1967-71.
15. Heidenreich PA, McDonald KM, Hastie T, et al. Meta-analysis of trials comparing b-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999;281:1927-36.
16. Rinaldi CA, Linka AZ, Masani ND, Avery PG, Jones E, Saunders H. Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide monotitrate on the time course and severity of exercise-lnduced myocardial stunning. Circulation 1998;98:749-56.
17. Zanchetti A, Bond MG, Hennig M, et al., on behalf of the ELSA Investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis. Principal results of the European Lacidipine Study on Atherosderosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002;106:2422-7.
18. Opie LH, Messerli FH. Nifedipine and mortality. Grave defects in the dossier. Circulation 1995;92:1068-73.
19. Brown MJ, Palmer CR, Castaigne A, de Leeuw P, Mancia G, Rosenthal T. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366-72.
20. Lubsen J, Poole-Wilson PA, Pocock SJ, et al. Design and current status of ACTION: a coronary, disease trial investigating outcome with nifedipine GITS. Eur Heart J 1998;19 Suppl I:I20-32.
21. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
22. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet 2000;356:1949-54.
23. Blood Pressure-Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;355:1955-64.